Biggest News Aggregation in the World
📰 Abdx News

Abdx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Abdx. Real-time updates on events, politics, business and more.

Abingdon Health (LON:ABDX) Sets New 1-Year High at $15.50

Abingdon Health Plc (LON:ABDX – Get Rating) shares hit a new 52-week high on Wednesday . The company traded as high as GBX 15.50 ($0.19) and last traded at GBX 15 ($0.19), with a volume of 834857 shares changing hands. The stock had previously closed at GBX 14.20 ($0.18). Abingdon Health Stock Up 5.6 % […]
Abingdon Health Company Profile Abingdon Health Abingdon Health Stock News Ratings For Abingdon Health Daily Abingdon Health Plc Get Rating

Abingdon Health (LON:ABDX) Stock Price Up 3.1%

Shares of Abingdon Health Plc (LON:ABDX – Get Rating) were up 3.1% on Wednesday . The stock traded as high as GBX 8.50 ($0.11) and last traded at GBX 8.25 ($0.10). Approximately 282,891 shares traded hands during trading, a decline of 16% from the average daily volume of 337,218 shares. The stock had previously closed […]
Abingdon Health Abingdon Health Plc News Ratings For Abingdon Health Daily Abingdon Health Trading Down Get Rating Health Trading Down
Source: wkrb13.com

Abingdon Health signs agreement with BioSure UK for distribution of rapid antibody in UK and Europe | 10 March 2021

Share price 10 March 2021 | 14:11pm StockMarketWire.com - International developer and manufacturer of rapid tests Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for the AbC-19 rapid neutralising antibody test with BioSure UK. Under the terms of the agreement, Abingdon Health and BioSure UK intend to establish a strategic distribution relationship to enable them to identify and maximise opportunities for the sale of the rapid neutralising antibod...
United Kingdom Chris Yates Abingdon Health Biosure United Biosure United Kingdom Lon Abdx

Abingdon Health reports wider losses in H1 as rising costs offset jump in revenue | 9 March 2021

9 March 2021 | 09:21am StockMarketWire.com - Developer and manufacturer of rapid tests Abingdon Health reported wider first-half losses as higher offset a jump in revenue, driven by COVID-19 tests sales. For the six months ended 31 December 2020, pre-tax losses widened to £1.571 million from £775,000, while revenue increased to £7.69 million from £1.55 million. The contract with the DHSC for the supply of COVID-19 rapid antibody test formed a substantial portion of its revenue for the peri...
Abingdon Health Lon Abdx Abdx L அபிங்டோன் ஆரோக்கியம்

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science